Carlos L. Arteaga, MD
Director, Center for Cancer Targeted Therapies
Associate Director for Clinical Research
Director, Breast Cancer Program & Professor of Medicine and Cancer Biology
Vanderbilt-Ingram Cancer Center, VUMC
2220 Pierce Ave.
790 Preston Research Building
An internationally renowned physician-scientist and prolific author, Arteaga leads the prestigious Vanderbilt National Cancer Institute Breast Cancer SPORE grant and is one of Stand Up to Cancer's Dream Team investigators. He took the reins of the American Association of Cancer Research as the national organization's 2014-15 president. Arteaga also serves on the scientific advisory board for the Susan G. Komen for the Cure Breast Cancer Foundation. A medical oncologist by training, Arteaga joined the faculty at Vanderbilt in 1989.
A new governor and many new legislators make 2019 a learning year as the state's top healthcare organizations seek to address a number of old issues and tweak some new solutions unveiled last year.
The American Heart Association and American College of Cardiology released updated cholesterol clinical guidelines in November 2018, taking a more nuanced approach to care over a patient's lifetime.
In an increasingly connected medical ecosystem where patient safety, health status improvement, and provider reimbursement are impacted at every point along the continuum, the need to efficiently, securely share data appears to have reached a tipping point.
A number of guideline changes and updates warrant more education around statin use and blood pressure monitoring, but local cardiologists say the higher standards are a game changer.
Dr. Ashish Shah is the driving force behind the growth and innovation at one of the nation's busiest heart transplant programs.
A TriStar Centennial, a team approach is key to hospital's successful ECMO program.
Sen. Lamar Alexander asks stakeholders and future leaders to weigh in on ways to improve health outcomes, lower costs.
Controlling pharmaceutical prices remains a hot topic, judging from the 6,415 comments received in response to the CMS proposed rule: "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses."
Every company should have a succession plan. LHC plays a key role in planning for the next generation of leaders for an entire industry.